Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation (CGC) generates a steady flow of news as a cannabis-focused manufacturer with operations spanning medical and adult-use markets, branded products, and vaporization devices. The Canopy Growth news page on Stock Titan aggregates these disclosures so readers can follow how the company’s strategy, financing, and operations evolve over time.
Company news frequently covers financial performance and capital structure. Canopy Growth issues quarterly results releases that discuss cannabis and Storz & Bickel net revenue, segment performance in Canada and international markets, gross margins, operating loss, adjusted EBITDA, and free cash flow, along with commentary on cost management and balance sheet strength. The company also announces financing transactions, such as term loan agreements, prepayments on senior secured debt, convertible debenture exchanges, and at-the-market equity programs.
Another major category of news involves corporate transactions and governance. Canopy Growth has reported entering into an arrangement agreement to acquire MTL Cannabis Corp., detailing consideration, required approvals, and expected strategic benefits. It also publishes results of its annual general and special meetings, including director elections, auditor appointments, share consolidation authority, and advisory votes on executive compensation, as well as updates on board and executive appointments.
Product and market updates are a recurring theme. The company announces launches such as Claybourne Gassers liquid diamonds All-in-One vapes and Claybourne Frosted Flyers infused pre-roll variety packs in Canada, along with expansions of the Spectrum Therapeutics medical portfolio in Australia through new softgel formats. It also highlights operational moves like dedicating the DOJA facility in Kelowna to medical cultivation for Spectrum Therapeutics patients.
Investors and observers who monitor CGC news can use this page to track developments in Canopy Growth’s Canadian adult-use and medical businesses, its international medical operations in Europe and Australia, its indirect exposure to the U.S. THC market through Canopy USA, and its ongoing efforts to manage debt, liquidity, and governance matters. Bookmark this feed to review new press releases, transaction updates, and regulatory communications as they are published.
Canopy Growth (NASDAQ: CGC) is executing a strategic arrangement to enhance its ownership in TerrAscend from approximately 13% to 21%. In exchange for this increment, Canopy Growth will divest its 27% stake in Canopy Rivers and pay $115 million, along with issuing 3,750,000 shares. The company will also increase its stake in Vert Mirabel from 41% to 67%. Additionally, terminating a royalty agreement will save Canopy Growth $2.9 million annually. This arrangement awaits approval from shareholders and regulatory bodies, marking a significant shift in Canopy Growth's investment strategy.
Canopy Growth has entered into a US$20 million loan agreement with Arise Bioscience Inc., a subsidiary of TerrAscend. The loan, secured by Arise's assets, will bear an interest rate of 6.10% per annum and matures on December 9, 2030. Additionally, Canopy has received 2,105,718 common share purchase warrants from TerrAscend. Proceeds from the loan will be used for general corporate purposes and debt repayment, without involvement in cannabis operations in the U.S. until compliant with laws.
BioSteel has secured a multi-year partnership with the Toronto Raptors, becoming the team's official sports drink and presenting partner for Raptors Training Camp. The deal allows BioSteel's new sugar-free sports drink to be available to players during games and training. Branding will be prominently displayed at home games and training facilities. BioSteel, founded in 2009, focuses on all-natural, nutritious products and has gained popularity among consumers and athletes alike. This partnership will further enhance BioSteel's market presence.
Canopy Growth Corporation (CGC) announced significant operational changes in Canada aimed at improving margins and accelerating profitability. The company plans to close multiple production sites, including locations in Newfoundland, New Brunswick, Alberta, and Ontario, impacting approximately 220 employees. This restructuring is part of a broader end-to-end review targeting $150-$200 million in cost savings. The closures represent about 17% of the company's Canadian footprint and are expected to incur pre-tax charges of $350-$400 million in the upcoming quarters.
Martha Stewart's CBD collection has officially launched at The Vitamin Shoppe and Super Supplements, marking a significant expansion for Canopy Growth Corporation (CGC). Available online and at over 580 retail locations, the product line includes a 15-Flavor CBD Gummy Sampler and various wellness products. The items, made from premium hemp-derived CBD isolate, aim to provide accessible wellness solutions just in time for the holiday shopping season. Consumers can enjoy a 25% discount on Martha Stewart wellness products through December 30, 2020, using promo code MARTHA25.
Summary not available.
BioSteel has entered a multi-year partnership with the Philadelphia 76ers, becoming the official sports drink of the team and the presenting partner for the 76ers Training Camp. This agreement includes significant brand visibility at home games and the team’s training complex in Camden, New Jersey, featuring digital signage and product placement. BioSteel's logo will be prominently displayed on various items during games. The partnership emphasizes BioSteel's commitment to providing sugar-free hydration products, aimed at enhancing athlete performance.
Canopy Growth Corporation has published a groundbreaking study on the long-term toxicity and lifespan effects of cannabidiol (CBD) using the preclinical model C. elegans. Conducted in partnership with NemaLife Inc., the study indicates that CBD shows no acute or chronic toxicity at physiological concentrations. Instead, it extends mean lifespan by up to 18% and increases late-stage life activity by 206%. This research, published in the Cannabis and Cannabinoid Research journal, supports ongoing investigations into CBD's potential health benefits and influences public policy regarding cannabis use.
Canopy Growth Corporation (NYSE: CGC) has launched a limited edition Martha Stewart CBD Wellness Gummies Sampler, featuring 60 gummies in 15 seasonal flavors for the holidays. Retailing at $64.99, the sampler will be available for pre-order starting November 11, with shipping set for November 27. The gummies contain 10mg of premium CBD isolate each, crafted to offer wellness benefits while being a luxurious gift option. This collaboration between Canopy Growth and Martha Stewart aims to enhance the CBD product line, appealing to consumers looking for both quality and flavor.
Canopy Growth Corporation (CGC) reported record quarterly net revenue of $135 million for Q2 Fiscal 2021, driven by robust sales in the Canadian recreational market and contributions from acquired brands.
Despite revenue growth, the company faced a net loss of $97 million but improved its Adjusted EBITDA loss to $86 million, a 43% reduction compared to Q2 FY20.
The firm aims to achieve $150-$200 million in cost savings and has seen a 200 basis point market share increase in Canada.